HealthIL2021 - Hit the Ground Running

Life Science

Q2Pharma Q2Pharma is developing a game-changing therapeutic for bacterial infections. F19 is a small-molecule drug that disarms the pathogen of disease-causing toxins and reverses resistance to conventional antibiotics in combination therapy. Treatment, Population Health Management, Personalized Medicine Tzofen Biological Therapeutics Tzofen Biological Therapeutics is a biotech company developing a novel biological platform, based on patentable genome sequences of Oncolytic Genetical Engineered Viruses (OGEV). Our unique technology is projected to transform the lives of millions of cancer patients around the world. Personalized Medicine, Treatment menachem@q2pharma.com | www.q2pharma.com

TZOFEN biological therapeutics

Dudi@Tzofen-bt.com | Tzofen-bt.com

21 Life Science HealthIL Week 2021